Dark

Check out our API

FTRP
Field Trip Health Ltd. Common Shares
stock NASDAQ

Inactive

Aug 16, 2022

4.21USD+1.068%(+0.04)32,885

Pre-market

0.00USD-100.000%(-4.17)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 28, 2022

04:35PM EST Understanding The Psilocybin Supply Chain: Every Production Method Explained Benzinga

Jan 18, 2022

08:00AM EST Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that Field Trips Co-Founder and CEO, Joseph del Moral, and Chief Scientific Officer, Dr. Nathan Bryson, will participate in Citis Psychedelic Drug Video Call Series. GlobeNewswire Inc

07:39AM EST Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS Benzinga

Jan 11, 2022

04:44PM EST Psychedelics Biotech Companies Mark New Milestones In Drug Development Pipelines: Field Trip, Cybin and Wesana Benzinga

10:21AM EST IIROC Trade Resumption - FTRP PR Newswire

10:02AM EST Field Trip Health Reports Received Notice Of Allowance For US Patent Application Covering FT-104 Novel Psychedelic Molecule In Development Benzinga

10:02AM EST IIROC Trading Halt - FTRP PR Newswire

10:00AM EST Field Trip Receives Notice of Allowance for US Patent Application GlobeNewswire Inc

Jan 6, 2022

08:00AM EST Field Trip Health Ltd. (NASDAQ: FTRP, TSX: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, today announced that it will begin making applications for Canadians in need to access psilocybin-assisted and MDMA-assisted therapy through Health Canadas Special Access Program (SAP). GlobeNewswire Inc

Jan 5, 2022

07:30AM EST Field Trip Health Ltd. to Participate in H.C. Wainwright GlobeNewswire Inc

Jan 4, 2022

02:11PM EST Understanding The Psilocybin Supply Chain: Every Production Method Explained Benzinga

10:58AM EST Stocks That Breached 52-Week Lows Today Benzinga

Jan 3, 2022

01:03PM EST Understanding The Psilocybin Supply Chain: Every Production Method Explained Benzinga

Dec 30, 2021

09:37AM EST 2021 Was The Year Psychedelics Conquered Capitalism...Or Is It The Other Way Around? Benzinga

Dec 22, 2021

12:33PM EST An iPhone App To Track Psychedelics & Cannabis Microdosing? Houston Lands On iOS Benzinga

Dec 14, 2021

07:30AM EST Field Trip Launches Site Management Organization (SMO) Services, GlobeNewswire Inc

Dec 1, 2021

07:30AM EST Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that management will present at H.C. Wainwrights 2nd Annual Psychedelics Conference and Stifels 2nd Annual Future of Healthcare Conference in December. GlobeNewswire Inc

Nov 22, 2021

06:29AM EST HC Wainwright & Co. Maintains Buy on Field Trip Health, Raises Price Target to $25 Benzinga

Nov 15, 2021

11:07AM EST Earnings Scheduled For November 15, 2021 Benzinga

Nov 3, 2021

07:30AM EDT Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that during the month of November management will attend the Microdose Wonderland: Miami Conference and present at the Stifel 2021 Virtual Healthcare Conference and the Jefferies London Healthcare Conference. GlobeNewswire Inc

Nov 2, 2021

07:30AM EDT Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial results for the fiscal second quarter ended September 30, 2021, after market close on Monday, November 15, 2021. GlobeNewswire Inc

Oct 26, 2021

01:49PM EDT Psyched: British PM Considers Psychedelics, New Partnership To Study Psilocybin For Autism, Compass Gets Another Patent Benzinga

Oct 19, 2021

03:00PM EDT Psychedelics Discussed At Benzinga Cannabis Capital Conference: Growth Opportunities, Mental Health & Pharma Benzinga

07:55AM EDT Field Trip Health Ltd. Continues Expansion GlobeNewswire Inc

Oct 18, 2021

01:37PM EDT Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation Benzinga

08:36AM EDT KCSA Psychedelics Virtual Investor Conference Presentations Available for PR Newswire

Oct 13, 2021

04:25PM EDT There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are Benzinga

Oct 12, 2021

07:31AM EDT Field Trip Health Ltd. To Present At The KCSA Psychedelics Virtual Investor PR Newswire

Oct 4, 2021

04:47PM EDT Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction Benzinga

Sep 29, 2021

02:52PM EDT Elon Musk Acknowledges Therapeutic Potential Of Psychedelic Drugs: Will This Impact The Markets? Benzinga

Sep 24, 2021

06:10PM EDT Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; Nasdaq: FTRP) ("Field Trip"), today announced the voting results from its Annual General and Special Meeting of Shareholders held onFriday, September 24, 2021.A total of 59.09% of the issued and outstanding common shares of the Corporation were represented either in person or by proxy at the meeting. GlobeNewswire Inc

Sep 14, 2021

12:54PM EDT Meet The Top 12 CEOs In The Psychedelics Industry Benzinga

Sep 13, 2021

01:37PM EDT Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics Benzinga

12:48PM EDT Meet The Top 12 CEOs In The Psychedelics Industry Benzinga

Sep 10, 2021

08:48AM EDT Field Trip Health Ltd. to Participate in Four Investor Conferences GlobeNewswire Inc

Sep 9, 2021

04:46PM EDT Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry? Benzinga

07:30AM EDT Field Trip Health Ltd. to Pursue Treatment Resistant Depression GlobeNewswire Inc

Sep 7, 2021

02:31PM EDT Psyched: Field Trip Gets $20 Price Target, DEA Seeks To Increase Psilocybin Production Limits, Synthesis Closes $7.25M Series A Benzinga

Sep 2, 2021

04:50PM EDT Field Trip Stock Could Climb 300% In One Year Benzinga

Sep 1, 2021

03:44PM EDT Why Field Trip Health Shares Are Trading Higher Today Benzinga

10:45AM EDT Toronto Stock Exchange, Field Trip Health Ltd., C-Suite at The Open PR Newswire

10:13AM EDT Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2021 Benzinga

06:14AM EDT HC Wainwright & Co. Initiates Coverage On Field Trip Health with Buy Rating, Announces Price Target of $20 Benzinga

Aug 31, 2021

07:55AM EDT Field Trip Health Ltd. Announces Launch Of Kap GlobeNewswire Inc

Aug 16, 2021

06:12PM EDT -- At June 30, 2021 had approximately $100 million in unrestricted cash and cash equivalents, funds held in trust and short-term investments -- Development of FT-104, a novel psychedelic molecule with pending patents, continues to progress with GMP production achieved -- The Company remains on track to meet milestone of 20 sites open or under construction by December 2021 GlobeNewswire Inc

Aug 10, 2021

07:55AM EDT Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial results for its first fiscal quarter ended June 30, 2021, after market close on Monday, August 16, 2021. GlobeNewswire Inc

Aug 2, 2021

10:08AM EDT Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected Benzinga

Jul 29, 2021

03:37PM EDT Field Trip Health Debuts On Nasdaq With Average Performance, Looks To Expand Footprint Of Psychedelics Clinics Benzinga

Share